Effects of angelica archangelica supplementation on overactive bladder in men and women: A randomized, double-blind, placebo-controlled trial

被引：0
|
作者：
Lopez-Seoane, J. [1 ]
Gesteiro, E. [1 ]
Pantoja-Arevalo, L. [1 ]
Quesada-Gonzalez, C. [2 ]
Rueda-Laorga, J. [1 ]
Portals-Riomao, A. [1 ]
Castro, M. J. [3 ]
Gonzalez-Gross, M. [1 ]
机构：
[1] Univ Politecn Madrid, Dept Hlth & Human Performance, ImFINE Res Grp, Madrid 28040, Spain
[2] Univ Politecn Madrid, Dept Math Appl Informat & Commun Technol, ImFINE Res Grp, Madrid 28040, Spain
[3] Univ Valladolid, Fac Nursing, Valladolid 47005, Spain
来源：
ANNALS OF NUTRITION AND METABOLISM | 2022年 / 78卷 / SUPPL 3期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PC070
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [1] Randomized, double-blind placebo-controlled trial with Bryophyllum pinnatum versus placebo for the treatment of overactive bladder in postmenopausal women
    Betschart, Cornelia
    von Mandach, Ursula
    Seifert, Burkhardt
    Scheiner, David
    Perucchini, Daniele
    Fink, Daniel
    Geissbuehler, Verena
    [J]. PHYTOMEDICINE, 2013, 20 (3-4) : 351 - 358
  • [2] Propiverine hydrochloride in Japanese patients with overactive bladder: A randomized, double-blind, placebo-controlled trial
    Gotoh, Momokazu
    Yokoyama, Osamu
    Nishizawa, Osamu
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (05) : 365 - 373
  • [3] Effects of Probiotic Supplementation on Metabolic Status in Pregnant Women: a Randomized, Double-blind, Placebo-Controlled Trial
    Jamilian, Mehri
    Bahmani, Fereshteh
    Vahedpoor, Zahra
    Salmani, Ali
    Tajabadi-Ebrahimi, Maryam
    Jafari, Parvaneh
    Dizaji, Shahrzad Hashemi
    Asemi, Zatollah
    [J]. ARCHIVES OF IRANIAN MEDICINE, 2016, 19 (10) : 687 - 692
  • [4] Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder
    Dmochowski, Roger R.
    Peters, Kenneth M.
    Morrow, Jon D.
    Guan, Zhonghong
    Gong, Jason
    Sun, Franklin
    Siami, Paul
    Staskin, David R.
    [J]. UROLOGY, 2010, 75 (01) : 62 - 68
  • [5] Randomized, Double-Blind, Placebo-Controlled Trial of Flexible-Dose Fesoterodine in Subjects With Overactive Bladder
    Kaplan, Steven A.
    [J]. JOURNAL OF UROLOGY, 2011, 186 (03): : 993 - 994
  • [6] Creatine Supplementation in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Alves, Christiano R. R.
    Santiago, Bianca M.
    Lima, Fernanda R.
    Otaduy, Maria C. G.
    Calich, Ana Luisa
    Tritto, Aline C. C.
    de Sa Pinto, Ana Lucia
    Roschel, Hamilton
    Leite, Claudia C.
    Benatti, Fabiana B.
    Bonfa, Eloisa
    Gualano, Bruno
    [J]. ARTHRITIS CARE & RESEARCH, 2013, 65 (09) : 1449 - 1459
  • [7] A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FLEXIBLE-DOSE FESOTERODINE FOR OVERACTIVE BLADDER
    Staskin, David R.
    Peters, Kenneth M.
    Morrow, Jon D.
    Guan, Zhonghong
    Gong, Jason
    Sun, Franklin
    Siami, Paul F.
    Dmochowski, Roger R.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2009, 28 (02) : 145 - 145
  • [8] The attention-enhancing effects of spearmint extract supplementation in healthy men and women: a randomized, double-blind, placebo-controlled, parallel trial
    Falcone, Paul H.
    Nieman, Kristin M.
    Tribby, Aaron C.
    Vogel, Roxanne M.
    Joy, Jordan M.
    Moon, Jordan R.
    Slayton, Chantelle A.
    Henigman, Micah M.
    Lasrado, Joanne A.
    Lewis, Brandon J.
    Fonseca, Brenda A.
    Herrlinger, Kelli A.
    [J]. NUTRITION RESEARCH, 2019, 64 : 24 - 38
  • [9] Efficacy of cinnamon patch treatment for alleviating symptoms of overactive bladder: A double-blind, randomized, placebo-controlled trial
    Chen, Lih-Lian
    Shen, Yuh-Chiang
    Ke, Chih-Chun
    Imtiyaz, Zuha
    Chen, Hui-, I
    Chang, Chin-Hsien
    Lee, Mei-Hsien
    [J]. PHYTOMEDICINE, 2021, 80
  • [10] A Multicenter, Double-blind, Randomized, Placebo-controlled Trial of the β3-Adrenoceptor Agonist Solabegron for Overactive Bladder
    Ohlstein, Eliot H.
    von Keitz, Alexander
    Michel, Martin C.
    [J]. EUROPEAN UROLOGY, 2012, 62 (05) : 834 - 840
12345